Integra LifeSciences Holdings (IART)

Integra LifeSciences Holdings Corporation is a healthcare company listed on NASDAQ under the ticker IART. Through its Codman Specialty Surgical and Tissue Technologies segments, the company develops and sells surgical instruments and a broad range of products used in neurosurgery, neurocritical care, otolaryngology, and wound care. Its portfolio includes tissue ablation equipment, dural repair products, cerebral spinal fluid management and intracranial monitoring devices, cranial stabilization tools, surgical headlamps, and related instrumentation. Integra also serves wound repair and reconstruction needs, with products used for acute and chronic wound treatment, hernia reinforcement, tendon protection, peripheral nerve repair, and plastics and surgical reconstruction. In addition, it has an ear, nose, and throat business that includes instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. The company sells through direct sales and other channels to hospitals, surgery centers, and healthcare providers in the United States, Europe, the Asia Pacific, and other international markets. It was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.